Abrdn Life Sciences Investors Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G, reporting beneficial ownership of 11.34% of abrdn Life Sciences Investors' common stock.
NYSE
First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation jointly reported a 10.09% beneficial ownership stake in abrdn Life Sciences Investors.
NYSE
First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly disclosed a 6.33% beneficial ownership stake in abrdn Life Sciences Investors, totaling 1,827,112 common shares.